The expression of epidermal growth factor receptor, HER-2/neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma

被引:60
作者
Swisher, EM [1 ]
Gown, AM [1 ]
Skelly, M [1 ]
Ek, M [1 ]
Tamimi, HK [1 ]
Cain, JM [1 ]
Greer, BE [1 ]
Muntz, HG [1 ]
Goff, BA [1 ]
机构
[1] UNIV WASHINGTON, SCH MED, DEPT PATHOL, SEATTLE, WA 98195 USA
关键词
D O I
10.1006/gyno.1996.0015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Uterine malignant mixed mesodermal tumors (MMMT) are highly malignant tumors containing both malignant glands and stroma, while adenosarcomas (AS) are less aggressive tumors composed of malignant stroma and benign glands. Immunohistochemistry was used to grade overexpression of p53 protein, HER-2/neu neu protein, epidermal growth factor receptor (EGFR), and Ki-67 antigen in both the glands and stroma of tissue from 20 women with MMMT and 6 women with AS. EGFR was overexpressed in 2 AS and 9 MMMT, and was more commonly found in the sarcomatous component than the carcinomatous component in MMMT (P = 0.03). p53 was not found in any AS samples and was strongly present in 6 MMMT samples with a random distribution between the malignant components. HER-2/neu protein was not overexpressed in any AS or primary MMMT. Ki-67 antigen, a marker of cell proliferation, was found at higher levels in MMMT than AS samples (P = 0.03) and high Ki-67 antigen expression correlated with a decreased survival in patients with MMMT (P = 0.004), Independent characterization of oncogene proteins in the malignant components of these heterogeneous tumors may provide insight into the histogenesis and behavior of these malignancies. (C) 1996 Academic Press, Inc.
引用
收藏
页码:81 / 88
页数:8
相关论文
共 32 条
[1]   OCCURRENCE OF EPIDERMAL GROWTH-FACTOR RECEPTORS IN HUMAN ADNEXAL TUMORS AND THEIR PROGNOSTIC VALUE IN ADVANCED OVARIAN CARCINOMAS [J].
BAUKNECHT, T ;
RUNGE, M ;
SCHWALL, M ;
PFLEIDERER, A .
GYNECOLOGIC ONCOLOGY, 1988, 29 (02) :147-157
[2]   EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN NORMAL OVARIAN EPITHELIUM AND OVARIAN-CANCER .1. CORRELATION OF RECEPTOR EXPRESSION WITH PROGNOSTIC FACTORS IN PATIENTS WITH OVARIAN-CANCER [J].
BERCHUCK, A ;
RODRIGUEZ, GC ;
KAMEL, A ;
DODGE, RK ;
SOPER, JT ;
CLARKEPEARSON, DL ;
BAST, RC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (02) :669-674
[3]  
BERCHUCK A, 1994, AM J OBSTET GYNECOL, V170, P246
[4]  
BERCHUCK A, 1990, CANCER RES, V50, P4087
[5]   EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN NORMAL AND MALIGNANT ENDOMETRIUM [J].
BERCHUCK, A ;
SOISSON, AP ;
OLT, GJ ;
SOPER, JT ;
CLARKEPEARSON, DL ;
BAST, RC ;
MCCARTY, KS .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 161 (05) :1247-1252
[6]   THE SIGNIFICANCE OF EPITHELIAL DIFFERENTIATION IN MIXED MESODERMAL TUMORS OF THE UTERUS - A CLINICOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY [J].
BITTERMAN, P ;
CHUN, B ;
KURMAN, RJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1990, 14 (04) :317-328
[7]   MULLERIAN ADENOSARCOMA OF THE UTERUS - A CLINICOPATHOLOGICAL ANALYSIS OF 100 CASES WITH A REVIEW OF THE LITERATURE [J].
CLEMENT, PB ;
SCULLY, RE .
HUMAN PATHOLOGY, 1990, 21 (04) :363-381
[8]  
COLTRERA MD, 1993, APPL IMMUNOHISTO M M, V1, P193
[9]  
COSTA J, 1984, CANCER, V53, P530, DOI 10.1002/1097-0142(19840201)53:3<530::AID-CNCR2820530327>3.0.CO
[10]  
2-D